JUMPSEAT
AEROSPACE NEWS

Bavarian Nordic Wins $97M US Contract

Key Takeaways
  • Bavarian Nordic awarded $97M contract options from the US government.
  • Contract covers production and supply of freeze-dried smallpox vaccines.
  • Options support manufacturing and delivery of 11.5 million doses.
  • Company upgrades full-year financial guidance.
Sign in to view key takeaways Get full access to in-depth analysis and key takeaways.
Sign In
Silver membership required Upgrade to Silver to access Key Takeaways.
Upgrade
Strategic Implications

This contract award may indicate the US government's continued focus on public health preparedness, which could benefit vaccine manufacturers like Bavarian Nordic. The partnership suggests a strong private-public collaboration in addressing emerging diseases and biological threats, which may set a precedent for future vaccine development and procurement.

Sign in to view strategic implications Get full access to strategic analysis and expert insights.
Sign In
Silver membership required Upgrade to Silver to access Strategic Implications.
Upgrade

What Happened

US Government Awards Vaccine Production Deal

Bavarian Nordic has been awarded contract options from the US government for the production and supply of freeze-dried smallpox vaccines, valued at $97 million. The contract supports the manufacturing and delivery of 11.5 million doses, with the majority of the contract value covering bulk vaccine production. The company has upgraded its full-year financial guidance following the award, as reported by GlobeNewswire.

Source

Advertisement 728 × 90
JUMPSEAT
AEROSPACE NEWS
JUMPSEAT
AEROSPACE NEWS

Bavarian Nordic Wins $97M US Contract

Sponsored by: Jumpseat Solutions
Key Takeaways
  • Bavarian Nordic awarded $97M contract options from the US government.
  • Contract covers production and supply of freeze-dried smallpox vaccines.
  • Options support manufacturing and delivery of 11.5 million doses.
  • Company upgrades full-year financial guidance.
Sign in to view key takeaways Get full access to in-depth analysis and key takeaways.
Sign In
Silver membership required Upgrade to Silver to access Key Takeaways.
Upgrade
Strategic Implications

This contract award may indicate the US government's continued focus on public health preparedness, which could benefit vaccine manufacturers like Bavarian Nordic. The partnership suggests a strong private-public collaboration in addressing emerging diseases and biological threats, which may set a precedent for future vaccine development and procurement.

Sign in to view strategic implications Get full access to strategic analysis and expert insights.
Sign In
Silver membership required Upgrade to Silver to access Strategic Implications.
Upgrade

What Happened

US Government Awards Vaccine Production Deal

Bavarian Nordic has been awarded contract options from the US government for the production and supply of freeze-dried smallpox vaccines, valued at $97 million. The contract supports the manufacturing and delivery of 11.5 million doses, with the majority of the contract value covering bulk vaccine production. The company has upgraded its full-year financial guidance following the award, as reported by GlobeNewswire.

Source

Advertisement 300 × 250 Google AdSense